AR and neoplasm: In primary ER-negative breast cancer, the prevalence of AR expression has ranged from 10% to 32%,20,21 likely reflecting differences in techniques as well thresholds for considering a tumor AR+ (i.e., ⩾1% vs. >10% of cells staining).